» Articles » PMID: 25737911

Additional Cytosine Inside Mitochondrial C-tract D-loop As a Progression Risk Factor in Oral Precancer Cases

Overview
Publisher Elsevier
Date 2015 Mar 5
PMID 25737911
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Alterations inside Polycytosine tract (C-tract) of mitochondrial DNA (mtDNA) have been described in many different tumor types. The Poly-Cytosine region is located within the mtDNA D-loop region which acts as point of mitochondrial replication origin. A suggested pathogenesis is that it interferes with the replication process of mtDNA which in turn affects the mitochondrial functioning and generates disease.

Methodology: 100 premalignant cases (50 leukoplakia & 50 oral submucous fibrosis) were selected and the mitochondrial DNA were isolated from the lesion tissues and from the blood samples. Polycytosine tract in mtDNA was sequenced by direct capillary sequencing.

Results: 40 (25 leukoplakia & 15 oral submucous fibrosis) patients harbored lesions that displayed one additional cytosine after nucleotide thymidine (7CT6C) at nt position 316 in C-tract of mtDNA which were absent in corresponding mtDNA derived from blood samples.

Conclusion: Our results show an additional cytosine in the mtDNA at polycytosine site in oral precancer cases. It is postulated that any increase/decrease in the number of cytosine residues in the Poly-Cytosine region may affect the rate of mtDNA replication by impairing the binding of polymerase and other transacting factors. By promoting mitochondrial genomic instability, it may have a central role in the dysregulation of mtDNA functioning, for example alterations in energy metabolism that may promote tumor development. We, therefore, report and propose that this alteration may represent the early development of oral cancer. Further studies with large number of samples are needed in to confirm the role of such mutation in carcinogenesis.

Citing Articles

Deregulation of mitochondrial gene expression in cancer: mechanisms and therapeutic opportunities.

Berner M, Wall S, Echeverria G Br J Cancer. 2024; 131(9):1415-1424.

PMID: 39143326 PMC: 11519338. DOI: 10.1038/s41416-024-02817-1.


G-quadruplex propensity in , and Denisovans mitochondrial genomes.

Brazda V, Sislerova L, Cucchiarini A, Mergny J NAR Genom Bioinform. 2024; 6(2):lqae060.

PMID: 38817800 PMC: 11137754. DOI: 10.1093/nargab/lqae060.

References
1.
El-Hattab A, Scaglia F . Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options. Neurotherapeutics. 2013; 10(2):186-98. PMC: 3625391. DOI: 10.1007/s13311-013-0177-6. View

2.
Grzybowska-Szatkowska L, Slaska B . Mitochondrial DNA and carcinogenesis (review). Mol Med Rep. 2012; 6(5):923-30. DOI: 10.3892/mmr.2012.1027. View

3.
Liu S, Jiang R, Chen F, Wang W, Lin J . Somatic mutations in the D-loop of mitochondrial DNA in oral squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2011; 269(6):1665-70. DOI: 10.1007/s00405-011-1806-5. View

4.
Sanchez-Cespedes M, Parrella P, Nomoto S, Cohen D, Xiao Y, Esteller M . Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res. 2001; 61(19):7015-9. View

5.
Liu Y, Xing L, Mi J, Chen L, Tian Y . Mitochondrial DNA mutations may not be frequent in patients with oral cancer. Mitochondrial DNA. 2013; 26(3):331-3. DOI: 10.3109/19401736.2013.834427. View